搜索
Collplant Biotechnologies Ltd
CLGN添加自选
0.340USD
-0.009-2.63%
收盘 07/02, 13:00（美东）报价延迟15分钟
4.36M总市值
亏损市盈率 TTM
关于 Collplant Biotechnologies Ltd 公司
CollPlant Biotechnologies Ltd, formerly known as Collplant Holdings Ltd, is a company dealing in aesthetic medicine and regenerative medicine based in Israel. The company provides products and technologies for broadly understood regenerative medicine, including tissue regeneration and organ production. The technology is based on plants and is based on the production of collagen type I (rhCollagen).
Collplant Biotechnologies Ltd简介
公司代码CLGN
公司名称Collplant Biotechnologies Ltd
上市日期Sep 01, 1993
CEORotem (Eran)
员工数量57
证券类型Ordinary Share
年结日Sep 01
公司地址4 Oppenheimer Street
城市REHOVOT
上市交易所NASDAQ OMX - NASDAQ BASIC
国家Israel
邮编7670104
电话972732325600
网址https://www.collplant.com
公司代码CLGN
上市日期Sep 01, 1993
CEORotem (Eran)
Collplant Biotechnologies Ltd公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Yehiel Tal
Mr. Yehiel Tal
Chief Executive Officer
Chief Executive Officer
56.14K
+44.53%
Mr. Eran Rotem, CPA
Mr. Eran Rotem, CPA
Deputy Chief Executive Officer, Chief Financial Officer
Deputy Chief Executive Officer, Chief Financial Officer
26.25K
--
Dr. Philippe David Bensimon
Dr. Philippe David Bensimon
Vice President - Regulatory Affairs and Quality Assurance
Vice President - Regulatory Affairs and Quality Assurance
15.13K
+86.78%
Dr. Abraham (Avri) Havron, Ph.D.
Dr. Abraham (Avri) Havron, Ph.D.
Independent Director
Independent Director
3.13K
--
Mr. Joseph Zarzewsky
Mr. Joseph Zarzewsky
Independent Director
Independent Director
3.13K
--
Ms. Alisa Lask
Ms. Alisa Lask
Independent Director
Independent Director
3.13K
--
Dr. Oded Shoseyov, Ph.D.
Dr. Oded Shoseyov, Ph.D.
Founder, Chief Scientist
Founder, Chief Scientist
--
--
Dr. Nadav Orr
Dr. Nadav Orr
Vice President - Research & Development
Vice President - Research & Development
--
--
Dr. Ilana Belzer, Ph.D.
Dr. Ilana Belzer, Ph.D.
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Gili Hart
Dr. Gili Hart
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Yehiel Tal
Mr. Yehiel Tal
Chief Executive Officer
Chief Executive Officer
56.14K
+44.53%
Mr. Eran Rotem, CPA
Mr. Eran Rotem, CPA
Deputy Chief Executive Officer, Chief Financial Officer
Deputy Chief Executive Officer, Chief Financial Officer
26.25K
--
Dr. Philippe David Bensimon
Dr. Philippe David Bensimon
Vice President - Regulatory Affairs and Quality Assurance
Vice President - Regulatory Affairs and Quality Assurance
15.13K
+86.78%
Dr. Abraham (Avri) Havron, Ph.D.
Dr. Abraham (Avri) Havron, Ph.D.
Independent Director
Independent Director
3.13K
--
Mr. Joseph Zarzewsky
Mr. Joseph Zarzewsky
Independent Director
Independent Director
3.13K
--
Ms. Alisa Lask
Ms. Alisa Lask
Independent Director
Independent Director
3.13K
--
常见问题
Collplant Biotechnologies Ltd的前五大股东是谁？
Collplant Biotechnologies Ltd 的前五大股东如下：Mr. Yehiel Tal
有多少机构持有Collplant Biotechnologies Ltd(CLGN)的股份？
截至2026Q1，共有35家机构持有Collplant Biotechnologies Ltd的股份，合计持有的股份价值约为1.89M，占公司总股份的13.14%。与2025Q4相比，机构持股有所增加，增幅为-218892.00。
哪个业务部门对Collplant Biotechnologies Ltd的收入贡献最大？
在2026Q1，Revenues from licensing agreement业务部门对Collplant Biotechnologies Ltd的收入贡献最大，创收2.00M，占总收入的84.35%。